ReviewCureus2025
New Paradigms in Nephrology Nursing.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the aging of the population and better healthcare, more elderly and frail patients are reaching the terminal stage of chronic kidney disease (CKD). In Portugal, one of the European leaders in the incidence of renal function replacement therapy, hemodialysis and peritoneal dialysis continue to be the focus of treatment, even in patients with multiple comorbidities, low functional reserve, and care dependency. However, several studies have revealed that these therapies in fragile patients do not provide quality of life or a greater survival rate but are associated with increased suffering due to the loss of functional capacity, with a subsequent need to abandon dialysis. Nephrology nursing in Portugal has always followed this more technical aspect necessary for dialysis. However, it has not dedicated itself to conservative treatment or other nephrology areas requiring differentiated palliative care, such as cardiorenal syndrome (CRS). Conservative treatment is a valid alternative that corresponds to the continuation of comprehensive therapy for patients with CKD without resorting to dialysis techniques. It seeks to prevent the deterioration of residual renal function while alleviating symptoms and complications resulting from disease progression, with personalized palliative care support aimed at optimizing the physical, emotional, and spiritual well-being of the patient and their family. On the other hand, despite being palliative, patients with CRS can benefit from more invasive techniques such as assisted peritoneal ultrafiltration to control symptoms, along with an educational approach that promotes their empowerment. This need for a paradigm shift led us to implement a specific nursing consultation for conservative treatment and CRS, ensuring personalized monitoring of these illnesses. Palliative care must be an integral part of healthcare, not only for incurable and terminal diseases but also for chronic, advanced, and evolving conditions.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.